|Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2|
ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ...
The Journal of Clinical Endocrinology & Metabolism 86 (12), 5658-5671, 2001
|Bisphosphonate‐associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research|
S Khosla, D Burr, J Cauley, DW Dempster, PR Ebeling, D Felsenberg, ...
Journal of bone and mineral research 22 (10), 1479-1491, 2007
|Medullary thyroid cancer: management guidelines of the American Thyroid Association|
RT Kloos, C Eng, DB Evans, GL Francis, RF Gagel, H Gharib, JF Moley, ...
Thyroid 19 (6), 565-612, 2009
|The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis|
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, RF Gagel, ...
Jama 276 (19), 1575-1579, 1996
|Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the American Thyroid Association Guidelines Task Force on medullary thyroid …|
SA Wells Jr, SL Asa, H Dralle, R Elisei, DB Evans, RF Gagel, N Lee, ...
Thyroid 25 (6), 567-610, 2015
|Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial|
SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, ...
Journal of clinical oncology 30 (2), 134, 2012
|Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy|
PM Thomas, GJ Cote, N Wohllk, B Haddad, PM Mathew, W Rabl, ...
Science 268 (5209), 426-429, 1995
|Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates|
AO Hoff, BB Toth, K Altundag, MM Johnson, CL Warneke, M Hu, A Nooka, ...
Journal of Bone and Mineral Research 23 (6), 826-836, 2008
|Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease|
H Neumann, DP Berger, G Sigmund, U Blum, D Schmidt, RJ Parmer, ...
New England Journal of Medicine 329 (21), 1531-1538, 1993
|Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer|
SA Wells Jr, JE Gosnell, RF Gagel, J Moley, D Pfister, JA Sosa, M Skinner, ...
Journal of Clinical Oncology 28 (5), 767, 2010
|Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer|
R Kurzrock, SI Sherman, DW Ball, AA Forastiere, RB Cohen, R Mehra, ...
Journal of Clinical Oncology 29 (19), 2660, 2011
|The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a|
RF Gagel, AH Tashjian Jr, T Cummings, N Papathanasopoulos, ...
New England Journal of Medicine 318 (8), 478-484, 1988
|Adrenal cortical carcinoma|
APB Dackiw, JE Lee, RF Gagel, DB Evans
World journal of surgery 25 (7), 914-926, 2001
|Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study|
CB Newman, S Melmed, PJ Snyder, WF Young, LD Boyajy, R Levy, ...
The Journal of Clinical Endocrinology & Metabolism 80 (9), 2768-2775, 1995
|RET Proto-Oncogene: A Review and Update of Genotype–Phenotype Correlations in Hereditary Medullary Thyroid Cancer and Associated Endocrine Tumors|
MA Kouvaraki, SE Shapiro, ND Perrier, GJ Cote, RF Gagel, AO Hoff, ...
Thyroid 15 (6), 531-544, 2005
|Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium|
LM Mulligan, DJ Marsh, BG Robinson, I Schuffenecker, J Zedenius, ...
Journal of internal medicine 238 (4), 343-346, 1995
|Octreotide as primary therapy for acromegaly|
CB Newman, S Melmed, A George, D Torigian, M Duhaney, P Snyder, ...
The Journal of Clinical Endocrinology & Metabolism 83 (9), 3034-3040, 1998
|American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules|
H Gharib, E Papini, R Valcavi, HJ Baskin, A Crescenzi, ME Dottorini, ...
Endocrine Practice 12 (1), 63-102, 2006
|ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes|
JG Guillem, WC Wood, JF Moley, A Berchuck, BY Karlan, DG Mutch, ...
Annals of surgical oncology 13 (10), 1296-1321, 2006
|Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients|
CC Solorzano, JE Lee, PWT Pisters, JN Vauthey, GD Ayers, ME Jean, ...
Surgery 130 (6), 1078-1085, 2001